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1. Introduction 
The tooth is a complex biological organ that consists of multiple tissues, including enamel, dentin, 
cementum, and pulp. Missing teeth is a common and frequently occurring problem in aging 
populations. To treat these defects, the current approach involves fixed or removable prostheses, 
autotransplantation, and dental implants. The exploration of new strategies for tooth replacement has 
become a hot topic. Using the foundations of experimental embryology, developmental and molecular 
biology, and the principles of biomimetics, tooth regeneration is becoming a realistic possibility. 
Several different methods have been proposed to achieve biological tooth replacement [1-8]. These 
include scaffold-based tooth regeneration, cell pellet engineering, chimeric tooth engineering, 
stimulation of the formation of a third dentition, and gene-manipulated tooth regeneration. The idea 
that a third dentition might be locally induced to replace missing teeth is an attractive concept [5,8,9]. 
This approach is generally presented in terms of adding molecules to induce de novo tooth initiation 
in the mouth. It might be combined with gene-manipulated tooth regeneration; that is, endogenous 
dental cells in situ can be activated or repressed by a gene-delivery technique to produce a tooth. 
Tooth development is the result of reciprocal and reiterative signaling between oral ectoderm-derived 
dental epithelium and cranial neural crest cell-derived dental mesenchyme under genetic control 
[10-12]. More than 200 genes are known to be expressed during tooth development 
(http://bite-it.helsinki.fi/). A number of mouse mutants are now starting to provide some insights into 
the mechanisms of supernumerary tooth formation.  Multiple supernumerary teeth may have genetic 
components in their etiology and partially represent the third dentition in humans. Such candidate 
molecules or genes might be those that are involved in embryonic tooth induction, in successional 
tooth formation, or in the control of the number of teeth. This means that it may be possible to induce 
de novo tooth formation by the in situ repression or activation of a single candidate gene. In this 
review, we present an overview of the collective knowledge of tooth regeneration, especially 
regarding the control of the number of teeth for gene therapy by the stimulation of a third dentition. 
 
2. The third dentition  
It has been suggested that, in humans, a “third dentition” with one or more supernumerary teeth can 
occur in addition to the permanent dentition, and supernumerary teeth are sometimes thought to 
represent a partial post-permanent dentition [13-15]. The basic dentition pattern observed in mammals 
is diphyodont, and consists of three incisors, one canine, four premolars, and three molars, while 
Human teeth are diphyodont excepting the permanent molars [16]. The deciduous teeth are, 
ontogenetically, the first generation of teeth. The permanent teeth (except molar) belong to the second 
dentition. The term “third dentition” refers to the opinion that one more set of teeth can occur in 
addition to the permanent teeth (Figure 1). Human teeth are diphyodont excepting the permanent 
molars. The normal mouse dentition is monophyodont and composed of one incisor and three molars 
in each quadrant. The number of teeth is usually strictly determined. It was initially reported that there 
is an anlagen of the third dentition in some mammals [17]. The presence of an epithelial anlagen of 
the third dentition was also noticed in humans [18,19]. The teeth and anlagen that appear in third 
dentition in serial sections of infant jaws and some fetuses have been analyzed. The epithelium which 
is considered as the anlagen of the third dentition develops lingual to all permanent tooth germs [15]. 
Furthermore, when it appears, the predecessor (permanent tooth germ) is in the bell-shaped stage [15]. 
The timing of appearance of the third dentition seems to be after birth (Table 1). This means that we 
have a chance to access the formation of the third dentition in the mouth. 
Analysis of other model systems with continuous tooth replacement or secondary tooth formation, 
such as in the fish, snake, lizard, and ferret, is providing insights into the molecular and cellular 
mechanisms underlying successional tooth development, and will assist in studies on supernumerary 
tooth formation in humans. While some nonmammalian species have multirowed dentition and 
replace their teeth regularly throughout life, mammalian vertebrates have one row of teeth and only 
renew their teeth once, or, in some rodents, show no replacement [20-23]. Detailed histological 
analysis of the tooth replacement in these models indicates that the successional teeth are initiated 
from the dental lamina epithelium, which grows from the lingual side of the deciduous tooth enamel 
organ, and it later elongates and buds into the jaw mesenchyme, forming successional teeth. Jarvien et 
al. showed that, in the ferret, Sostdc1 (also known as USAG-1, ectodin, and Wise) is expressed in the 
elongating successional dental lamina at the interface between the lamina and deciduous tooth, as 
well as the buccal side of the dental lamina, suggesting that Sostdc1 plays a role in defining the 
identity of the dental lamina [20]. Handrigan et al. analyzed successional tooth formation in the snake 
and in lizard, and proposed that dental epithelium stem cells are responsible for the formation of 
successional lamina, and Wnt signaling may regulate the stem cell fate in these cells [24]. 
Maintenance or reactivation of component dental lamina is thus pivotal for the replacement tooth and 
supernumerary formation. 
 
3. Human syndromes associated with supernumerary teeth 
Supernumerary teeth can be associated with a syndrome (Table 2) or they can be found in 
non-syndromic patients [25-28]. Only 1% of non-syndromic cases have multiple supernumerary teeth, 
which occur most frequently in the mandibular premolar area, followed by the molar and anterior 
regions, respectively [29-34]. There are special cases exhibiting permanent supernumerary teeth 
developing as supplementary teeth forming after the permanent teeth. These are thought to represent a 
third dentition, best known as manifestations of cleidocranial dysplasia (CCD). 
Genetic mutations have been associated with the presence or absence of individual types of teeth. 
Supernumerary teeth are associated with more than 20 syndromes and developmental abnormalities 
like CCD, and Gardner syndrome [35]. The percentage occurrence in CCD is 22% in the maxillary 
incisor region and 5% in the molar region [36-38]. CCD is a dominantly inherited skeletal dysplasia 
caused by mutations in RUNX2 [39-40]. It is characterized by persistently open sutures or the delayed 
closure of sutures, hypoplastic or aplastic clavicles, a short stature, delayed eruption of permanent 
dentition, supernumerary teeth, and other skeletal anomalies. There is a wide spectrum of phenotypic 
variability ranging from the full-blown phenotype to an isolated dental phenotype characterized by 
supernumerary tooth formation and/or the delayed eruption of permanent teeth in CCD (Figure 1) 
[41-44]. A dose-related effect seems to be present, as the milder case of CCD, and those exhibiting 
primary dental anomalies, are related to mutations that reduce, but do not abolish, protein stability, 
DNA binding, and transactivation [41,43-45]. Runx2-deficient mice were found to exhibit lingual 
buds in front of the upper molars, and these were much more prominent than in wild-type mice 
[46,47]. These buds presumably represent the mouse secondary dentition, and it is likely that RUNX2 
acts to prevent the formation of these buds. RUNX2 usually functions as a cell growth inhibitor [43]. 
Runx2 regulates the proliferation of cells and may exert specific control on the dental lamina and 
formation of successive dentitions. Runx2 heterozygous mutant mice mostly phenocopied the skeletal 
defects of CCD in humans, but with no supernumerary tooth formation [48] (Otto, 1997). Notably, in 
Runx2 homozygous and heterozygous mouse upper molars, a prominent epithelial bud regularly 
presents. This epithelial bud protrudes lingually with active Shh signaling, and it may represent the 
extension of the dental lamina for successional tooth formation in mice. Hence, although Runx2 is 
required for primary tooth development, it prevents the growth of the dental lamina and successional 
tooth formation [47]. 
Familial adenomatous polyposis (FAP), also named adenomatous polyposis of the colon (APC), is an 
autosomal dominant hereditary disorder characterized by the development of many precancerous 
colorectal adenomatous polyps, some of which will inevitably develop into cancer. In addition to 
colorectal neoplasm, individuals can develop variable extracolonic lesions, including upper 
gastrointestinal polyposis, osteomas, congenital hypertrophy of the retinal pigment epithelium, soft 
tissue tumors, desmoid tumors, and dental anomalies [49-53]. Dental abnormalities include impacted 
teeth, congenital absence of one or more teeth, supernumerary teeth, dentigerous cysts associated with 
the crown of an unerupted tooth, and odontomas [50,52]. Gardner syndrome is a variant of FAP 
characterized by multiple adenomas of the colon and rectum typical of FAP together with osteomas 
and soft tissue tumors[49,51]. Supernumerary teeth and osteomas were originally described as a part 
of Gardner syndrome, but they can also occur in FAP patients with or without other extracolonic 
lesions [51,52]. FAP and Gardner syndrome are caused by a large number of germinal mutations in 
the APC gene [52,53]. APC is a tumor suppressor gene involved in the down-regulation of free 
intracellular ß-catenin, the major signal transducer of the canonical Wnt signaling pathway, as well as 
a central component of the E-cadherin adhesion complex [54,55]. In addition, the APC protein may 
also play roles in chromosomal stability, the regulation of cell migration up the colonic crypt and cell 
adhesion through association with GSK3ß, and other functions associated with microtubule bundles 
[55,56]. Inactivation of APC would lead to the stabilization and accumulation of the proto-oncogene 
ß-catenin, disregulation of the cell cycle, and chromosomal instability [52]. Approximately 11-27% of 
patients have supernumerary teeth, but, so far, no specific codon mutation of the APC gene has been 
found to correlate with supernumerary teeth. Correlations seems to exist between dental abnormalities 
and the number and type of osteomas, with the highest incidence of supernumerary teeth and 
odontomas being found in FAP patients with three or more osteomas [52]. Conditional knockout of 
the Apc-gene resulted in supernumerary teeth in mice [57-59] . Notably, adult oral tissues, especially 
young adult tissues, are still responsive to the loss of Apc [60]. In old adult mice, supernumerary teeth 
can be induced on both labial and lingual sides of the incisors, which contain adult stem cells 
supporting the continuous growth of mouse incisors [60,61]. In young mice, supernumerary tooth 
germs were induced in multiple regions of the jaw in both incisor and molar regions. They can form 
directly from the oral epithelium, in the dental lamina connecting the developing molar or incisor 
tooth germ to the oral epithelium, in the crown region, as well as in the elongating and furcation area 
of the developing root [60]. 
The identification of mutations in RUNX2 causing an isolated dental phenotype in CCD and in APC 
causing FAP has attracted attention as a possible route towards inducing de novo tooth formation.  
 
4. Supernumerary tooth formation in a mouse model  
The number of teeth is usually strictly determined. Whereas evidence supporting a genetic etiology 
for tooth agenesis is well established, the etiology of supernumerary tooth formation is only partially 
understood in the mouse model (Table 3). Unlike humans, mice have only molars and incisors 
separated by a toothless region called the diastema. In addition, mice only have a single primary 
dentition and their teeth are not replaced. Therefore, mice may not be an optimal model for studying 
tooth replacement and supernumerary tooth formation [62]. Most of the reported mouse 
supernumerary teeth are located in the diastema region. This is not a de novo tooth formation but the 
rescue of vestigial tooth rudiments. During the early stages of tooth development, many transient 
vestigial dental buds develop in the diastema area. Some of them can develop into the bud stage, but 
later regress and disappear by apoptosis, or merge with the mesial crown of the first molar 
tooth[63-68]. Major signaling pathways regulating tooth development are also expressed in these 
vestigial dental buds. Modulation of these signals can rescue these vestigial tooth rudiments to 
develop into supernumerary diastema teeth [23]. A number of mutant mouse strains have been 
reported exhibiting supernumerary diastema teeth. Although the rudimentary tooth buds form in the 
embryonic diastema, they regress apoptically [69]. Transgenic mice in which the keratin 14 promoter 
directs Ectodysplasin (Eda), a member of the tumor necrosis factor (TNF) family of signaling 
molecules, or Eda receptor expression to the epithelium had supernumerary teeth mesial to the first 
molar as a result of diastema tooth development [70-72]. It has also been reported that Sprouty2 
(Spry2) or Spry4 (which encode negative feedback regulators of fibroblast growth factor (FGF)) 
deficient mice showed supernumerary tooth formation as a result of diastema tooth development [73]. 
Hypomorphic Polaris mice and Wnt-Cre (Polaris conditional mutant mice with affected Shh 
signaling) [73-74], Pax6 mutant mice [75] and Gas1 null mutants [73] were also included. Uterine 
sensitization associated gene-1 (USAG-1) is a BMP antagonist, and also modulates Wnt signaling. We 
reported that USAG-1-deficient mice have supernumerary teeth (Figure 2).  
The supernumerary maxillary incisor appears to form as a result of the successive development of the 
rudimentary upper incisor. USAG-1 abrogation rescued apoptotic elimination of odontogenic 
mesenchymal cells [14]. BMP signaling in the rudimentary maxillary incisor, assessed by expressions 
of Msx1 and Dlx2 and the phosphorylation of Smad protein, was significantly enhanced. Wnt 
signaling, as demonstrated by the nuclear localization of β-catenin, was also up-regulated. The 
inhibition of BMP signaling rescues supernumerary tooth formation in E15 incisor explant culture. 
Based upon these results, we conclude that enhanced BMP signaling results in supernumerary teeth 
and BMP signaling was modulated by Wnt signaling in the USAG-1-deficient mouse model (Figure 
3) [76]. Canonical Wnt/β-catenin signaling and its down-stream molecule Lef-1 are essential for tooth 
development [77].  
Overexpression of Lef-1 under the control of the K14 promoter in transgenic mice leads to the 
development abnormal invaginations of the dental epithelium in the mesenchyme and formation of a 
tooth-like structure [78]. De novo supernumerary teeth arising directly from the primary tooth germ or 
dental lamima have been reported in Apc loss-of-function (as discussed in the previous section) or 
β-catenin gain-of-function mice, and Sp6 (Epiprofin)-deficient mice. It was demonstrated that mouse 
tooth buds expressing stabilized β-catenin give rise to extra teeth [58] (Jarvinen et al., 2006). More 
recently, Epiprofin (Epfn) (a zinc finger transcription factor belonging to the Sp transcription factor 
superfamily)-deficient mice developed an excess number of teeth [79]. Mammals only have one row 
of teeth in each jaw. Interestingly, in the Osr2 null mutant mouse embryo, supernumerary tooth germs 
were found developing directly from the oral epithelium lingual to their molar tooth germs [80]. More 
recently, we also demonstrated that CEBPB deficiency was related to the formation of supernumerary 
teeth [81]. A total of 66.7% of CEBPB-/- 12-month-olds sustained supernumerary teeth and/or 
odontomas in the diastema between the incisor and the first molar. Two supernumerary teeth 
accompanied with an a10 complex odontoma near the root of the upper right incisor were identified in 
a CEBPB-/- adult (Figure 2), whilst two other CEBPB-/- mice simply showed a supernumerary tooth 
in the upper left quadrant. Another CEBPB-/- adult mouse did not display any supernumerary teeth in 
either jaw, but an odontoma in the lower-right quadrant. All of the CEBPB-/- adults appeared with a 
normal number of erupted incisors and molars. Nevertheless, 20% of the CEBPB+/- 12-month-olds 
had a missing lower third molar. Dental anomalies such as supernumerary teeth, odontomas, or 
hypodontia were not found in mice of any other genotypes and/or age [81].  
These mouse models clearly demonstrated that it was possible to induce de novo tooth formation by 
the in situ repression or activation of single candidate gene such as USAG-1. 
 
5. Gene therapy approaches 
Gene therapy provides a unique tool for the delivery of previously identified signaling molecules in 
both time and space that may significantly augment our progress toward clinical tooth regeneration. 
Stimulation of the formation of a third dentition and gene-manipulated tooth regeneration comprise an 
attractive concept (Figure 4). This approach is generally presented in terms of adding molecules to 
induce de novo tooth initiation in the mouth. It might be combined with gene-manipulated tooth 
regeneration; that is, endogenous dental cells in situ can be activated or repressed by a gene-delivery 
technique to make a tooth. We have a chance to access the formation of the third dentition in the 
mouth, because the time of appearance of the third dentition seems to be after birth. As the half-life of 
targeted proteins in vivo is transient, tooth regeneration is not a common outcome following 
conventional therapy. Typically, high concentrations are required to promote regeneration [82]). 
Therefore, supplemental local production via gene transfer could be superior to bolus delivery 
methods.  
Simply stated, gene therapy consists of the insertion of genes into an individual’s cells directly or 
indirectly with a matrix to promote a specific biological effect. Gene therapy can be used to induce a 
more favorable host response. Targeting cells for gene therapy requires the use of vectors or direct 
delivery methods to transfect them. To overcome the short half-lives of peptides in vivo, gene therapy 
that uses a vector that encodes the candidate genes is utilized to stimulate the formation of the third 
dentition. The two main strategies of gene vector delivery have been applied. Gene vectors can be 
introduced directly to the target site (in vivo gene delivery) [83] or selected cells can be harvested, 
expanded, genetically transduced, and then reimplanted (ex vivo gene delivery). In vivo gene transfer 
involves the insertion of the gene of interest directly into the body, anticipating the genetic 
modification of the target cells. Ex vivo gene transfer includes the incorporation of genetic material 
into cells exposed from a tissue biopsy with subsequent reimplantation into the recipient. So far, in 
vivo gene delivery has been a suitable gene therapy approach in tooth regeneration by stimulation of 
the third dentition, but ex vivo gene delivery is not realistic because of the poor availability of ideal 
cells.  
Gene transfer is accomplished through the use of viral and nonviral vectors. The three main classes of 
virus used for gene therapy are the retrovirus, adenovirus, and adenoassociated viruses. Retroviruses 
are ideal for long-term gene therapy since, once introduced, their DNA integrates and becomes part of 
the genome of the host cells. Indeed, the current human genome contains up to 5 to 8% of endogenous 
retroviral sequences that have been acquired over the course of evolution [84]. Adenoviruses are more 
commonly suited for short-term gene delivery and are highly targeted for tissue engineering strategies 
that desire protein production over the course of several weeks. Efficient adenovirus-directed gene 
delivery to odontogenic ectomsenchymal cells derived from cranial neural crest cells was reported 
[85,86]. In addition, because the adenovirus is well-known as the “virus of the common cold,” 
infection is generally nontoxic and self-limiting. However, determination of the genotoxicity for each 
specific application is necessary to keep the safety profile within acceptable parameters. 
Adenoassociated viruses have become the focus of much research in recent years because of their 
complete inability to replicate without a helper virus, potential for tissue-specific targeting, and gene 
expression in the order of months to years. The ability to specifically target one tissue type without 
adverse effects on neighboring tissues is highly desired in fields such as tooth regeneration. On the 
other hand, nonviral methods are safe and do not require immunosuppression for successful gene 
delivery, but suffer from lower transfection efficiencies. DNA injection followed by application of 
electric fields (electroporation) has been more effective for introducing DNA than the use of simple 
DNA injection [87]. However, this method involves the concern that the electric pulse causes tissue 
damage. Recently, we reported that gene transfer using an ultra-fine needle [88], in addition to 
microbubbles enhanced transcutaneous sonoporation [87].     
In vivo gene delivery seems to be a suitable gene therapy approach in tooth regeneration by 
stimulation of the third dentition. 
 
6. Conclusion 
We have a chance to access the formation of the third dentition in the mouth, because the timing of 
the appearance of the third dentition seems to be after birth. The identification of mutations in RUNX2 
causing an isolated dental phenotype in CCD and supernumerary tooth formation in the mouse model 
clearly demonstrated that it was possible to induce de novo tooth formation by the in situ repression 
or activation of a single candidate gene. These results support the idea that the de novo repression or 
activation of candidate genes such as RUNX2 or USAG-1 might be used to stimulate the third 
dentition in order to induce new tooth formation in the mouse (Figure 4). In vivo gene delivery seems 
to be a suitable gene therapy approach in tooth regeneration by stimulation of the third dentition. 
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 Figure 1. Multiple impacted supernumerary teeth in a 13-year-old non-syndromic patient. The third 
dentition develops lingual to the permanent tooth germ (D). All impacted supernumerary teeth in this 
patient are located to the lingual side of the permanent teeth (white arrow) (A-C). These multiple 
supernumerary teeth seem to be post-permanent dentition (“third dentition”).  
 
Table 1 Timing of appearance of the third dentition 
 
Table 2 Human syndromes associated with supernumerary teeth 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 Mutant mouse associated with supernumerary teeth 
 
 
 
 
 
 
 Figure 2. Supernumerary teeth formation in Sostdc 1 (USAG-1) (A-C) and CEBPB (D-H) adult 
mutant mice. A: Oblique view of the maxillary incisors. B: Occlusal view of the mandibular incisors. 
C: Occlusal view of the mandibular molars. Micro-CT images (D-F) and HE-staining (G,H) of the 
murine head. A frontal view (D), a sagittal view (E) and a horizontal view (F) showed supernumerary 
tooth (red arrow). Two supernumerary teeth and a odontoma were seen in a low (G) and a high (H) 
magnification.   
 
 
 
 
  
 
 Figure 4. In vivo gene delivery approach for the tooth regeneration by stimulation of a third dentition. 
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